Company / Current Assets
Kymera Therapeutics, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$871.2M
FY2025
5-year range
$405.3M / $871.2M
FY2021-FY2025
Trend
+70.7%
vs FY2024
Sector context
#64 of 213
Health Care
What the data says
At $871M, Kymera Therapeutics, Inc.'s current assets ranks #64 of 213 in the Health Care sector. Improved from $405M to $871M over the past 2 years.
Based on SEC 10-K filings.
$871M in FY2025 with a 5-year CAGR of +23.6%.
Improved from $405M to $871M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +27.6%
- 5-Year CAGR
- +23.6%
- 10-Year CAGR
- -
Sector benchmark
#64 of 213 in Health CareTop 30% of 213This company $871.2M Sector average $2.5B
▼
-65.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.6%, indicating consistent growth.
- In FY2025, current assets increased 70.7% year-over-year.
- Ranks #64 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $871.2M | +70.7% |
| FY2024 | $510.3M | +25.9% |
| FY2023 | $405.3M | -3.4% |
| FY2022 | $419.4M | -7.1% |
| FY2021 | $451.3M | +49.3% |
| FY2020 | $302.3M | +225.6% |
| FY2019 | $92.8M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026